---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-308342"
form_type: "8-K"
ticker: "RGNX"
cik: "0001590877"
company_name: "REGENXBIO Inc."
filed_at: "2026-07-20T11:34:30+00:00"
generated_at: "2026-07-20T11:35:05.461956+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# REGENXBIO prices $100M public offering of common stock and pre-funded warrants

## Summary
- Offering of 10,003,889 shares at $9.00/share and 1,111,111 pre-funded warrants at $8.9999 each.
- Gross proceeds ~$100M; net proceeds ~$107.8M after underwriters' full exercise of 1,667,250 option shares.
- Underwriters: Morgan Stanley, J.P. Morgan, Leerink Partners, Mizuho Securities.
- Expected to close July 20, 2026, subject to customary conditions.
- Pre-funded warrants have $0.0001 exercise price, exercisable immediately, no expiration.

## SEC filing metadata
- accession: 0001193125-26-308342
- form_type: 8-K
- ticker: RGNX
- cik: 0001590877
- company_name: REGENXBIO Inc.
- filed_at: 2026-07-20T11:34:30+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590877/000119312526308342/0001193125-26-308342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590877/000119312526308342/d40931d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-308342
- JSON: https://secwatch.observer/filing/0001193125-26-308342.json
- Plain text: https://secwatch.observer/filing/0001193125-26-308342.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.